Atlas Trials

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Clinical trial NCT01917552 · UNKNOWN

Trial details

NCT number
NCT01917552
Sponsor
Asan Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2013-08-19
Primary completion
2026-08-01
Enrollment
870

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.